Replies to post #94920 on Biotech Values

[DewDiligence]

ACOR—Ampyra logged $30M of in-market sales in 2Q10, the first full quarter since product launch:

http://finance.yahoo.com/news/Acorda-Therapeutics-Reports-bw-4119763881.html?x=0&.v=1